Geographic variation in inhaled corticosteroid use for children with persistent asthma in Medicaid

References

• van Essen-Zandvliet EE, Hughes MD, Waalkens HJ, Duiverman EJ, Pocock SJ, Kerrebijn KF. Effects of 22 months of treatment with inhaled corticosteroids and/or beta-2-agonists on lung function, airway responsiveness, and symptoms in children with asthma. The Dutch Chronic Non-specific Lung Disease Study Group. Am Rev Respir Dis 1992;146(3):547–554.
   PubMedGoogle Scholar
• Pauwels RA, Pedersen S, Busse WW, Tan WC, Chen YZ, Ohlsson SV, et al. Early intervention with budesonide in mild persistent asthma: a randomised, double-blind trial. Lancet 2003;361(9363):1071–1076.
   PubMed Web of Science ®Google Scholar
• National Heart Lung and Blood Institute. Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma (EPR-3), 2007. Available from: https://www.nhlbi.nih.gov/health-pro/guidelines/current/asthma-guidelines [last accessed 7 June 2017].
   Google Scholar
• Goodman DE, Israel E, Rosenberg M, Johnston R, Weiss ST, Drazen JM. The influence of age, diagnosis, and gender on proper use of metered-dose inhalers. Am J Respir Crit Care Med 1994;150(5Pt 1):1256–1261.
   PubMedGoogle Scholar
• Melani AS, Bonavia M, Cilenti V, Cinti C, Lodi M, Martucci P, et al. Inhaler mishandling remains common in real life and is associated with reduced disease control. Respir Med 2011;105(6):930–938.
   PubMed Web of Science ®Google Scholar
• Hardwell A, Barber V, Hargadon T, McKnight E, Holmes J, Levy ML. Technique training does not improve the ability of most patients to use pressurised metered-dose inhalers (pMDIs). Prim Care Respir J 2011;20(1):92–96.
   PubMedGoogle Scholar
• Capanoglu M, Dibek Misirlioglu E, Toyran M, Civelek E, Kocabas CN. Evaluation of inhaler technique, adherence to therapy and their effect on disease control among children with asthma using metered dose or dry powder inhalers. J Asthma 2015;52(8):838–845.
   PubMed Web of Science ®Google Scholar
• Driesenaar JA, De Smet PA, van Hulten R, Horne R, Zwikker HE, van den Bemt BJ, et al. Beliefs about inhaled corticosteroids: comparison of community pharmacists, pharmacy technicians and patients with asthma. J Asthma 2016;53(10):1051–1058.
   PubMed Web of Science ®Google Scholar
• Horne R, Weinman J. Self-regulation and self-management in asthma: exploring the role of illness perceptions and treatment beliefs in explaining non-adherence to preventer medication. Psychol Health 2002;17(1):17–32.
   Web of Science ®Google Scholar
• Van Steenis M, Driesenaar J, Bensing J, Van Hulten R, Souverein P, Van Dijk L, et al. Relationship between medication beliefs, self-reported and refill adherence, and symptoms in patients with asthma using inhaled corticosteroids. Patient Prefer Adher 2014;8:83–91.
   PubMed Web of Science ®Google Scholar
• Menckeberg TT, Bouvy ML, Bracke M, Kaptein AA, Leufkens HG, Raaijmakers JA, et al. Beliefs about medicines predict refill adherence to inhaled corticosteroids. J Psychosom Res 2008;64(1):47–54.
   PubMed Web of Science ®Google Scholar
• Smith LA, Bokhour B, Hohman KH, Miroshnik I, Kleinman KP, Cohn E, et al. Modifiable risk factors for suboptimal control and controller medication underuse among children with asthma. Pediatrics 2008;122(4):760–769.
   PubMed Web of Science ®Google Scholar
• Koster ES, Wijga AH, Koppelman GH, Postma DS, Brunekreef B, De Jongste JC, et al. Uncontrolled asthma at age 8: the importance of parental perception towards medication. Pediatr Allergy Immunol 2011;22(5):462–468.
   PubMed Web of Science ®Google Scholar
• Patlak M. Strategies to overcome ‘steroid phobia’. Am Coll Physicians Obs 2004.
   Google Scholar
• Michigan Department of Community Health. Asthma Burden for Children in Medicaid, 2012. Available from: http://getasthmahelp.org/documents/Asthma_for_Children_in_Medicaid_2012.pdf [last accessed 7 June 2017].
   Google Scholar
• Finkelstein JA, Barton MB, Donahue JG, Algatt-Bergstrom P, Markson LE, Platt R. Comparing asthma care for Medicaid and non-Medicaid children in a health maintenance organization. Arch Pediatr Adolesc Med 2000;154(6):563–568.
   PubMedGoogle Scholar
• Fang G, Brooks JM, Chrischilles EA. Comparison of instrumental variable analysis using a new instrument with risk adjustment methods to reduce confounding by indication. Am J Epidemiol 2012;175(11):1142.
   PubMed Web of Science ®Google Scholar
• Wilson SE, Leonard A, Moomaw C, Schneeweiss S, Eckman MH. Underuse of controller medications among children with persistent asthma in the Ohio medicaid population: evolving differences with new medications. Ambul Pediatr 2005;5(2):83–89.
   PubMedGoogle Scholar
• Mathematica Policy Research. Encounter Data Toolkit, 2013. Available from: https://www.medicaid.gov/medicaid-chip-program-information/by-topics/delivery-systems/downloads/medicaid-encounter-data-toolkit.pdf [last accessed 7 June 2017].
   Google Scholar
• Mathematica Policy Research. Collecting, Using, and Reporting Medicaid Encounter Data: A Primer for States, 2011. Available from: https://www.cms.gov/research-statistics-data-and-systems/computer-data-and-systems/medicaiddatasourcesgeninfo/downloads/max_pdq_task_x_encounterdataprimerforstates.pdf [last accessed 7 June 2017].
   Google Scholar
• Centers for Medicare & Medicaid Services. MAX 1999–2005 State Claims Anomalies, 2010. Available from: https://www.cms.gov/research-statistics-data-and-systems/computer-data-and-systems/medicaiddatasourcesgeninfo/maxgeneralinformation.html [last accessed 7 June 2017].
   Google Scholar
• Fang G, Brooks JM, Chrischilles EA. A new method to isolate local-area practice styles in prescription use as the basis for instrumental variables in comparative effectiveness research. Med Care 2010;48(8):710–717.
   PubMed Web of Science ®Google Scholar
• Ward A, Willey C, Andrade S. Medications prescribed to asthmatic children: an historical cohort study comparing clinical practice with NIH recommendations. Pharmacoepidemiol Drug Saf 2000;9(6):511–520.
   PubMed Web of Science ®Google Scholar
• Wu AC, Butler MG, Li L, Fung V, Kharbanda EO, Larkin EK, et al. Primary adherence to controller medications for asthma is poor. Ann Am Thorac Soc 2015;12(2):161–166.
   PubMed Web of Science ®Google Scholar
• Suissa S, Ernst P, Boivin JF, Horwitz RI, Habbick B, Cockroft D, et al. A cohort analysis of excess mortality in asthma and the use of inhaled beta-agonists. Am J Respir Crit Care Med 1994;149(3Pt 1):604–610.
   PubMedGoogle Scholar
• Miller MK, Lee JH, Miller DP, Wenzel SE. Recent asthma exacerbations: a key predictor of future exacerbations. Respir Med 2007;101(3):481–489.
   PubMed Web of Science ®Google Scholar
• Boulet LP, Boulay ME. Asthma-related comorbidities. Expert Rev Respir Med 2011;5(3):377–393.
   PubMed Web of Science ®Google Scholar
• Brozek JL, Bousquet J, Baena-Cagnani CE, Bonini S, Canonica GW, Casale TB, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision. J Allergy Clin Immunol 2010;126(3):466–476.
   PubMed Web of Science ®Google Scholar
• Skoner DP. The tall and the short: repainting the landscape about the growth effects of inhaled and intranasal corticosteroids. Allergy Asthma Proc 2016;37(3):180–191.
   PubMed Web of Science ®Google Scholar
• Keast SL, Thompson D, Farmer K, Smith M, Nesser N, Harrison D. Impact of a prior authorization policy for montelukast on clinical outcomes for asthma and allergic rhinitis among children and adolescents in a state Medicaid program. J Manag Care Spec Pharm 2014;20(6):612–621.
   PubMed Web of Science ®Google Scholar
• Lloyd PC, Simon AE, Parker JD. Characteristics of children in Medicaid managed care and Medicaid fee-for-service, 2003–2005. Natl Health Stat Report 2015(80):1–15.
   Google Scholar